Susan M. Blaney, MD
- Texas Medical Center
Executive Vice Chair, Department of Pediatrics, Baylor College of Medicine
Deputy Director, Cancer and Hematology Centers, Texas Children’s Hospital
Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
|Walter Reed Army Medical Center||fellowship||Pediatric Hematology Oncology, PHEM||1990|
|Letterman Army Medical Center||residency||Pediatrics, PEDI||1987|
|Albany Medical College||internship||Pediatrics, PEDI||1985|
|Medical College of Ohio at Toledo||medical school||Doctor of Medicine, M.D.||1984|
About Susan Blaney
Dr. Susan Blaney is the Deputy Director of the Texas Children's Cancer and Hematology Centers and Executive Vice Chair of the Department of Pediatrics at Baylor College of Medicine (BCM). She is also the Vice Chair of the Children's Oncology Group, the National Cancer Institute (NCI) supported clinical trials group and the world's largest organization devoted exclusively to pediatric cancer research.
Dr. Blaney served as the Co-Director of the Developmental Therapeutics Program at Texas Children's Cancer Center where she performs pre-clinical and clinical studies of new antineoplastic agents. A primary focus of her research is the development of new drugs for the treatment of central nervous system tumors in children with a particular emphasis on the development of new agents for intrathecal administration.
For more information, visit Dr. Susan Blaney's profile on VIICTR.
New Drug Development
American Board of Pediatrics
American Board of Pediatrics-Hematology/Oncology
|American Association Cancer Research (AACR)||Member|
|American Society Clinical Oncology (ASCO)||Member|
|American Society Pediatric Hematology/Oncology (ASPHO)||Member|
|Children's Oncology Group (COG)||Vice Chair; Executive Committee; Scientific Council|
|Pediatric Brain Tumor Consortium (PBTC)||Steering and Executive Committee Member|
Pre-clinical and clinical studies of new antineoplastic agents
Central nervous system tumors
New agents for intrathecal administration